LB
Therapeutic Areas
ENDRA Life Sciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TAEUS® Liver | Quantification of Hepatic Steatosis (NAFLD/NASH) | Commercial (CE Mark) |
| TAEUS® Platform Expansion | Tissue Temperature Monitoring (e.g., surgery) | Research & Development |
| Nexus 128 | Pre-clinical Research Imaging | Commercial |
Leadership Team at ENDRA Life Sciences
AT
Alexander Tokman
CEO & Director
RJ
Richard Jacroux
Chief Financial Officer
ZR
Ziad Rouag
Head of Clinical and Regulatory
IS
Idan Steinberg
Head of Engineering
SS
Scott Sober
Head of Operations
AD
Anthony DiGiandomenico
Director
MH
Michael Harsh
Director